SENSEI BIOTHERAPEUTICS INC (SNSE)
US81728A1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 89% to SNSE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.34. This target is 795.66% above the current price.
SNSE was analyzed by 11 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about SNSE.
In the previous month the buy percentage consensus was at a similar level.
SNSE was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | Citigroup | Reiterate | Buy -> Buy |
| 2024-05-24 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | Stephens & Co. | Initiate | Overweight |
| 2023-12-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-12-13 | Citigroup | Initiate | Buy |
| 2022-10-03 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2022-03-10 | Piper Sandler | Maintains | Overweight |
| 2021-07-01 | Berenberg | Downgrade | Buy -> Hold |
| 2021-06-29 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2021-03-01 | Oppenheimer | Initiate | Outperform |
| 2021-03-01 | Piper Sandler | Initiate | Overweight |